Flavonoids inhibit the genotoxicity of hydrogen peroxide (H2O2) and of the food mutagen 2-amino-3-methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD)

Mutagenesis

Volumn 24, Issue 5, 2009, Pages 405-411

  Najafzadeh, Mojgan ^a   Reynolds, P Dominic ^a,b   Baumgartner, Adolf ^a   Anderson, Diana ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; EPICATECHIN; HYDROGEN PEROXIDE; QUERCETIN; QUINOLINE DERIVATIVE;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROHN DISEASE; DIET SUPPLEMENTATION; DNA DAMAGE; ENTERITIS; FRUIT; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; SOYBEAN; TEA; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGING; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA DAMAGE; FEMALE; FLAVONOIDS; FOOD; HUMANS; HYDROGEN PEROXIDE; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; MUTAGENS; QUINOLINES; SEX CHARACTERISTICS; SMOKING;

GLYCINE MAX;

EID: 71949125739     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gep016     Document Type: Article

References (58)

1. Schut, H. A. and Snyderwine, E. G. (1999) DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis. Carcinogenesis, 20, 353-368.
2. Adamson, R. H., Thorgeirsson, U. P. and Sugimura, T. (1996) Extrapolation of heterocyclic amine carcinogenesis data from rodents and nonhuman primates to humans. Arch. Toxicol. Suppl., 18, 303-318.
3. Bogen, K. T. (1994) Cancer potencies of heterocyclic amines found in cooked foods. Food Chem. Toxicol., 32, 505-515.
4. Schwab, C. E., Huber, W. W., Parzefall, W., Hietsch, G., Kassie, F., Schulte-Hermann, R. and Knasmuller, S. (2000) Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit. Rev. Toxicol., 30, 1-69.
5. Eisenbrand, G. and Tang, W. (1993) Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities. A literature review. Toxicology, 84, 1-82.
6. Murata, M., Kobayashi, M. and Kawanishi, S. (1999) Mechanism of oxidative DNA damage induced by a heterocyclic amine, 2-amino-3, 8- dimethylimidazo[4, 5f]quinoxaline. Jpn. J. Cancer Res., 90, 268-275.
7. Weisburger, J. H., Barnes, W. S., Lovelette, C. A., Tong, C., Tanaka, T. and Williams, G. M. (1986) Genotoxicity, carcinogenicity, and mode of action of the fried food mutagen 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ). Environ. Health Perspect., 67, 121-127.
8. Maeda, H., Sawa, T., Yubisui, T. and Akaike, T. (1999) Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH. Cancer Lett., 143, 117-121.
9. Rice-Evans, C. (2001) Flavonoid antioxidants. Curr. Med. Chem., 8, 797-807.
10. Noroozi, M., Angerson, W. J. and Lean, M. E. (1998) Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr., 67, 1210-1218.
11. Kaur, G., Roberti, M., Raul, F. and Pendurthi, U. R. (2007) Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol. Thromb. Res., 119, 247-256.
12. Danese, S. and Fiocchi, C. (2006) Etiopathogenesis of inflammatory bowel diseases. World J. Gastroenterol., 12, 4807-4812.
13. Seegert, D., Rosenstiel, P., Pfahler, H., Pfefferkorn, P., Nikolaus, S. and Schreiber, S. (2001) Increased expression of IL-16 in inflammatory bowel disease. Gut, 48, 326-332. (Pubitemid 32269559)
14. Rezaie, A., Parker, R. D. and Abdollahi, M. (2007) Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci., 52, 2015-2021.
15. Soffler, C. (2007) Oxidative stress. Vet. Clin. North Am. Equine Pract., 23, 135-157.
16. Hemnani, T. and Parihar, M. S. (1998) Reactive oxygen species and oxidative DNA damage. Indian J. Physiol. Pharmacol., 42, 440-452.
17. Davies, K. J. (1995) Oxidative stress: The paradox of aerobic life. Biochem. Soc. Symp., 61, 1-31.
18. Spoettl, T., Hausmann, M., Klebl, F., Dirmeier, A., Klump, B., Hoffmann, J., Herfarth, H., Timmer, A. and Rogler, G. (2007) Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm. Bowel Dis., 13, 727-732.
19. Ardizzone, S. and Bianchi Porro, G. (2005) Biologic therapy for inflammatory bowel disease. Drugs, 65, 2253-2286.
20. Rogler, G. (2004) Update in inflammatory bowel disease pathogenesis. Curr. Opin. Gastroenterol., 20, 311-317. (Pubitemid 38813671)
21. Helio, T., Halme, L., Lappalainen, M., Fodstad, H., Paavola-Sakki, P., Turunen, U., Farkkila, M., Krusius, T. and Kontula, K. (2003) CARD15/ NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut, 52, 558-562.
22. Bonen, D. K. and Cho, J. H. (2003) The genetics of inflammatory bowel disease. Gastroenterology, 124, 521-536.
23. McGovern, D. P., van Heel, D. A., Ahmad, T. and Jewell, D. P. (2001) NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut, 49, 752-754.
24. Marks, D. J. and Segal, A. W. (2008) Innate immunity in inflammatory bowel disease: a disease hypothesis. J. Pathol., 214, 260-266.
25. Braun, J. and Wei, B. (2007) Body traffic: Ecology, genetics, and immunity in inflammatory bowel disease. Annu. Rev. Pathol., 2, 401-429.
26. Cho, J. H. (2001) The Nod2 gene in Crohn's disease: Implications for future research into the genetics and immunology of Crohn's disease. Inflamm. Bowel Dis., 7, 271-275.
27. Moller, P. (2006) The alkaline comet assay: Towards validation in biomonitoring of DNA damaging exposures. Basic Clin. Pharmacol. Toxicol., 98, 336-345.
28. Sachse, C., Smith, G., Wilkie, M. J., Barrett, J. H., Waxman, R., Sullivan, F., Forman, D., Bishop, D. T. and Wolf, C. R. (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis, 23, 1839-1849.
29. Henderson, L., Wolfreys, A., Fedyk, J., Bourner, C. and Windebank, S. (1998) The ability of the Comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis, 13, 89-94.
30. Tice, R. R., Agurell, E., Anderson, D. et al. (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen., 35, 206-221.
31. Hartmann, A., Agurell, E., Beevers, C. et al. (2003) Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis, 18, 45-51.
32. Kumaravel, T. S., Vilhar, B., Faux, S. P. and Jha, A. N. (2009) Comet assay measurements: a perspective. Cell Biol. Toxicol., 25, 53-64.
33. Faust, F., Kassie, F., Knasmuller, S., Boedecker, R. H., Mann, M. and Mersch-Sundermann, V. (2004) The use of the alkaline comet assay with lymphocytes in human biomonitoring studies. Mutat. Res., 566, 209-229.
34. Adamson, R. H. and Thorgeirsson, U. P. (1995) Carcinogens in foods: heterocyclic amines and cancer and heart disease. Adv. Exp. Med. Biol., 369, 211-220.
35. Knize, M. G., Dolbeare, F. A., Cunningham, P. L. and Felton, J. S. (1995) Mutagenic activity and heterocyclic amine content of the human diet. Princess Takamatsu Symp., 23, 30-38.
36. Goldman, R. and Shields, P. G. (2003) Food mutagens. J. Nutr., 133 (Suppl. 3), 965S-973S.
37. Anderson, D., Dobrzynska, M. M., Basaran, N., Basaran, A. and Yu, T. W. (1998) Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm. Mutat. Res., 402, 269-277.
38. Schoeffner, D. J. and Thorgeirsson, U. P. (2000) Susceptibility of nonhuman primates to carcinogens of human relevance. In Vivo, 14, 149-156.
39. Hatch, F. T., Knize, M. G. and Colvin, M. E. (2001) Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: Structural, electronic, and hydropathic factors affecting mutagenic potency. Environ. Mol. Mutagen., 38, 268-291.
40. Wolz, E., Pfau, W. and Degen, G. H. (2000) Bioactivation of the food mutagen 2-amino-3-methyl-imidazo[4, 5-f]quinoline (IQ) by prostaglandin- H synthase and by monooxygenases: DNA adduct analysis. Food Chem. Toxicol., 38, 513-522.
41. Sugimura, T. and Sato, S. (1983) Mutagens-carcinogens in foods. Cancer Res., 43, 2415s-2421s.
42. Bashir, M., Kingston, D. G., Carman, R. J., van Tassell, R. L. and Wilkins, T. D. (1987) Anaerobic metabolism of 2-amino-3-methyl-3Himidazo[ 4, 5-f]quinoline (IQ) by human fecal flora. Mutat. Res., 190, 187-190.
43. Carman, R. J., Van Tassell, R. L., Kingston, D. G., Bashir, M. and Wilkins, T. D. (1988) Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutat. Res., 206, 335-342.
44. Van Tassell, R. L., Kingston, D. G. and Wilkins, T. D. (1990) Metabolism of dietary genotoxins by the human colonic microflora; the fecapentaenes and heterocyclic amines. Mutat. Res., 238, 209-221.
45. Rumney, C. J., Rowland, I. R. and O'Neill, I. K. (1993) Conversion of IQ to 7-OHIQ by gut microflora. Nutr. Cancer, 19, 67-76.
46. Knasmuller, S., Steinkellner, H., Hirschl, A. M., Rabot, S., Nobis, E. C. and Kassie, F. (2001) Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat. Res., 480-481, 129-138.
47. Reddy, B. S. and Rivenson, A. (1993) Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino- 3-methylimidazo[4, 5-f]quinoline, a food mutagen. Cancer Res., 53, 3914-3918.
48. Undeger, U., Aydin, S., Basaran, A. A. and Basaran, N. (2004) The modulating effects of quercetin and rutin on the mitomycin C induced DNA damage. Toxicol. Lett., 151, 143-149. (Pubitemid 38739036)
49. de Whalley, C. V., Rankin, S. M., Hoult, J. R., Jessup, W. and Leake, D. S. (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol., 39, 1743-1750.
50. Ren, W., Qiao, Z., Wang, H., Zhu, L. and Zhang, L. (2003) Flavonoids: Promising anticancer agents. Med. Res. Rev., 23, 519-534.
51. Jankun, J., Selman, S. H., Swiercz, R. and Skrzypczak-Jankun, E. (1997) Why drinking green tea could prevent cancer. Nature, 387, 561.
52. Terao, J. (1999) Dietary flavonoids as antioxidants in vivo: Conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma. J. Med. Invest., 46, 159-168.
53. Zhanataev, A. K., Kulakova, A. V., Nasonova, V. V. and Durnev, A. D. (2008) In vivo study of dihydroquercetin genotoxicity. Bull. Exp. Biol. Med., 145, 338-340.
54. Lee, J. C., Kim, J., Park, J. K., Chung, G. H. and Jang, Y. S. (2003) The antioxidant, rather than prooxidant, activities of quercetin on normal cells: Quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Exp. Cell Res., 291, 386-397.
55. Papiez, M. A., Cierniak, A., Krzysciak, W., Bzowska, M., Taha, H. M., Jozkowicz, A. and Piskula, M. (2008) The changes of antioxidant defense system caused by quercetin administration do not lead to DNA damage and apoptosis in the spleen and bone marrow cells of rats. Food Chem. Toxicol., 46, 3053-3058.
56. Najafzadeh, M., Reynolds, P. D. and Baumgartner, A. (2007) Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. Biofactors, 31, 191-200.
57. Kruidenier, L., Kuiper, I., Lamers, C. B. and Verspaget, H. W. (2003) Intestinal oxidative damage in inflammatory bowel disease: Semiquantification, localization, and association with mucosal antioxidants. J. Pathol., 201, 28-36.
58. Sventoraityte, J., Zvirbliene, A., Kiudelis, G., Zalinkevicius, R., Zvirbliene, A., Praskevicius, A., Kupcinskas, L. and Tamosiunas, V. (2008) Immune system alterations in patients with inflammatory bowel disease during remission. Medicina (Kaunas), 44, 27-33.